Track topics on Twitter Track topics that are important to you
Interface between StarDrop and Plexus facilitates seamless access to both software platforms
Cambridge, UK, and Budapest, Hungary, 15 April, 2015 - Optibrium™ and ChemAxon™, developers of software and cheminformatics solutions for drug discovery, today announced the results of a collaboration to integrate ChemAxon’s Plexus™ with Optibrium’s StarDrop™ software suite. The integration of these platforms further enables researchers to develop strategies for efficient, high quality compound library design.
The StarDrop software platform from Optibrium facilitates multi-parameter optimisation, property prediction and data visualisation to guide the design of high quality compounds for drug discovery projects. ChemAxon’s Plexus is a web based collaborative discovery platform which enables scaffold- and reaction-based enumeration of compound libraries.
As a result of the collaboration, a seamlessly integrated workflow and user interface is available in StarDrop for the application of Plexus to enumerate compound libraries. These are returned as data sets within StarDrop for detailed analysis, visualisation and selection of compounds with an optimised balance of the properties required for success.
Matthew Segall, CEO of Optibrium, will provide an overview of the results of this collaboration at ChemAxon's European User Group Meeting being held in Budapest, Hungary, May 19-20.
For further information on Optibrium and StarDrop, please visit www.optibrium.com/stardrop/ or contact email@example.com
For further information on ChemAxon, please visit www.chemaxon.com or contact firstname.lastname@example.org. To find out more about Plexus Suite and its modules, visit the Plexus Suite product page.
ChemAxon is a leader in providing cheminformatics software platforms and desktop applications for the biotechnology, pharmaceutical and agrochemical industries. We focus on active interaction with users and software portability to create powerful, cost-effective cross platform solutions that power modern cheminformatics and chemical communication. The company is privately owned with European headquarters in Budapest, US East Coast headquarters in Cambridge, MA, and sales and support offices in Europe, Japan and across North America.
About Optibrium Ltd.
Optibrium provides elegant software solutions for small molecule design, optimisation and data analysis. Optibrium’s portfolio of products includes:
Founded in 2009, Optibrium continues to develop new products and research novel technologies to improve the efficiency and productivity of the drug discovery process. Optibrium works closely with its broad range of customers and collaborators that include leading global pharma, agrochemical and flavouring companies, biotech and academic groups.
Visit the online community at http://www.optibrium.com/community/ for further discussions on improving the productivity of drug discovery.Media contact Sarah Jeffery Zyme Communications E-mail: email@example.com Phone: +44 (0)7771 730919 Optibrium Nick Foster Director, Business Development E-mail: firstname.lastname@example.org Phone: +44 (0)1223 815900 ChemAxon Ágnes Peragovics Product Owner, Plexus Design E-mail: email@example.comNEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...